Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.

Cimsit C., Kursun M., Demircioglu O., Dilber F., Demirtas C. O., Ergenc I.
Academic radiology , cilt.30, 2023 (SCI-Expanded) identifier identifier

Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index

DEMİRTAŞ C. Ö., Ricco G., ÖZDOĞAN O. C., BALTACIOĞLU F., ÖNEŞ T., YUMUK P. F., et al.
HEPATOLOGY COMMUNICATIONS , cilt.6, sa.12, ss.3600-3601, 2022 (SCI-Expanded) identifier identifier identifier

Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy

GÜNDÜZ F., DURAK S., ÜNSAL Y., DEMİR M., Ellik Z. M., YILDIRIM A. E., et al.
JOURNAL OF HEPATOLOGY , cilt.77, 2022 (SCI-Expanded) identifier

Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders

DEMİRTAŞ C. Ö., Ricco G., ÖZDOĞAN O. C., BALTACIOĞLU F., Ones T., YUMUK P. F., et al.
HEPATOLOGY COMMUNICATIONS , cilt.6, sa.3, ss.633-645, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?

Fulgenzi C. A. M., D'Alessio A., Ogunbiyi O., DEMİRTAŞ C. Ö., Gennari A., Cortellini A., et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS , cilt.31, ss.681-691, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Impact of COVID-19 Pandemic on Gastroenterology Fellowship Training in Turkey: A Prospective Nationwide Survey Study

DEMİRTAŞ C. Ö., Vahabov C., Mustafayev F., Sahin T., PARLAK E.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.10, ss.879-891, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

MODELLING THE DYNAMICS OF CANCER CELLS AND TUMOR VASCULATURE IN HCC PATIENTS TREATED WITH TKIs OR TACE

Colombatto P., Damone F., Ricco G., Oliveri F., Civitano L., Romagnoli V., et al.
HEPATOLOGY , cilt.74, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?

DEMİRTAŞ C. Ö., Brunetto M. R.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.27, sa.33, ss.5536-5554, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease

KANİ H. T., DEMİRTAŞ C. Ö., KEKLİKKIRAN Ç., Ergenc I., Mehdiyev S., AKDENİZ E., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.8, ss.661-666, 2021 (SCI-Expanded) identifier identifier identifier identifier

Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study

DEMİRTAŞ C. Ö., Tolu T., KEKLİKKIRAN Ç., ÖZDOĞAN O. C., GÜNDÜZ F.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.8, ss.685-693, 2021 (SCI-Expanded) identifier identifier identifier identifier

Proposal and validation of a novel scoring system for hepatocellular carcinomas beyond curability borders: Unresectable hepatocellular carcinoma prognostic index

DEMİRTAŞ C. Ö., Ricco G., ÖZDOĞAN O. C., BALTACIOĞLU F., ÖNEŞ T., YUMUK P. F., et al.
JOURNAL OF HEPATOLOGY , cilt.75, 2021 (SCI-Expanded) identifier

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib

Colombatto P., DEMİRTAŞ C. Ö., Ricco G., Civitano L., Boraschi P., Scalise P., et al.
CANCERS , cilt.13, sa.9, 2021 (SCI-Expanded) identifier identifier identifier

Letter: Is female sex an independent predictor of favourable prognosis in hepatocellular carcinoma?

Demirtas C. O., Gunduz F.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.52, ss.1765-1766, 2020 (SCI-Expanded) identifier identifier identifier

Myeloperoxidase and calprotectin; Any role as non-invasive markers for the prediction of inflammation and fibrosis in non-alcoholic steatohepatitis?

Bicakci E., DEMİRTAŞ C. Ö., ÇELİKEL Ç., HAKLAR G., DUMAN D.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, sa.10, ss.681-687, 2020 (SCI-Expanded) identifier identifier identifier

Validation and reliability of the Turkish version of the inflammatory bowel disease questionnaire for ulcerative colitis and Crohn's disease

KANİ H. T., Ergenc I., Arikan H., Komesli Z., Seyrek B., DEMİRTAŞ C. Ö., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, sa.8, ss.566-572, 2020 (SCI-Expanded) identifier identifier identifier

A large Turkish pedigree with multiple endocrine neoplasia type 1 syndrome carrying a rare mutation: c.1680_1683 del TGAG

Demirtaş C. Ö., Ata P., Çetin A., Turkyilmaz A., Duman D.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.31, ss.508-514, 2020 (SCI-Expanded) identifier identifier identifier

The optimal controlled attenuation parameter cut-offs in hepaticsteatosis grade differentiation by transient elastography(Fibroscan) in a sample of biopsy-proven non-alcoholic fatty liverdisease patients

Kaya E., BAKIR A., Sapmaz A. F., Kayyali T., Quatranji L., Çiftaslan A., et al.
Hepatology International , cilt.13, ss.196, 2019 (SCI-Expanded) identifier

Convenient chronic hepatitis B candidates for antiviral cessation and retreatment after relapse: When and who?

DEMİRTAŞ C. Ö., ÖZDOĞAN O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.6, ss.720-721, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

Diğer Dergilerde Yayınlanan Makaleler

Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma

ALAN A. M., ALAN Ö., ASADOV R., DEMİRTAŞ C. Ö., KANİ H. T., YUMUK P. F., et al.
Hepatology forum , cilt.4, sa.2, ss.53-60, 2023 (Scopus) identifier identifier identifier

The preliminary data of gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Turkish population in HBV related hepatocellular carcinoma

BİRCAN KADIOĞLU D., DEMİRTAŞ C. Ö., PİRİM D., Gündüz F., EREN F.
Hepatology forum , 2023 (ESCI)

Characteristics of patients with hepatocellular carcinoma: A multicenter study

Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.
HEPATOLOGY FORUM , cilt.3, sa.3, ss.71-76, 2022 (ESCI) Creative Commons License identifier identifier identifier identifier

Programmed Cell Death 1 and Hepatocellular Carcinoma: An Epochal Story

DEMİRTAŞ C. Ö., GÜNDÜZ F.
JOURNAL OF GASTROINTESTINAL CANCER , cilt.52, sa.4, ss.1217-1222, 2021 (ESCI) identifier identifier identifier

Surveillance Strategies for Hepatocellular Carcinoma: Recent Advances and the Shifting Paradigm

DEMİRTAŞ C. Ö., GÜNDÜZ F., ÖZDOĞAN O. C.
JOURNAL OF GASTROINTESTINAL CANCER , cilt.52, sa.4, ss.1336-1339, 2021 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma

DEMİRTAŞ C. Ö., 'Alessio A., Rimassa L., Sharma R., Pinato D. J.
JHEP REPORTS , cilt.3, sa.5, 2021 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

The natural course of gastric intestinal metaplasia in Turkish patients: A single-center observational cohort study

DEMİRTAŞ C. Ö., Koldas M., Yilmaz M., Sahin M. Z., Soykuvvet M. T., ÇELİKEL Ç., et al.
MARMARA MEDICAL JOURNAL , cilt.34, sa.3, ss.229-233, 2021 (ESCI) Sürdürülebilir Kalkınma identifier

Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions

Demirtas C. O., ÖZDOĞAN O. C.
HEPATOLOGY FORUM , cilt.1, sa.3, ss.112-118, 2020 (ESCI) Creative Commons License identifier identifier

The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance

DEMİRTAŞ C. Ö., SAPMAZ A., GÜREL B. A., KIZMAZ H., ULU T., KARAKETİR Ş. G., et al.
Hepatology Forum , cilt.1, sa.3, ss.101-108, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma identifier

Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?

DEMİRTAŞ C. Ö., YILMAZ Y.
Hepatology Forum , cilt.1, sa.3, ss.79-81, 2020 (Hakemli Dergi) identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

“The gene expressions and bioinformatics analysis of miR-146b-5p and miR-4510 in Hepatocellular Carcinoma”

BİRCAN KADIOĞLU D., DEMİRTAŞ C. Ö., PİRİM D., Gündüz F., EREN F.
EASL Liver Cancer Summit, Estoril, Portekiz, 20 Nisan 2023, ss.134-135

ARTERIAL STIFFNESS IS INDEPENDENTLY ASSOCIATED WITH LIVER STIFFNESS IN BIOPSY-PROVEN NON-ALCOHOLIC FATTY LIVER DISEASE: A TRANSIENT ELASTOGRAPHY STUDY

Bilgin B. O., SÜNBÜL M., Kani H. T., Demirtas C. O., KEKLİKKIRAN Ç., YILMAZ Y.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70 identifier

USEFULNESS OF ENDOSCOPIC ULTRASONOGRAPHY ELASTOGRAPHY (EUS-E) TO MEASURE LIVER STIFFNESS

Duman D. G., Alahdab Y., Demirtas C. O., YILMAZ Y., GÜNDÜZ F.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70 identifier

Annual contrast-enhanced MRI is highly effective in the surveillance of hepatocellular carcinoma in cirrhotic patients

DEMİRTAŞ C. Ö., GÜNDÜZ F., TÜNEY D., BALTACIOĞLU F., ÖZEN ALAHDAB Y., ÖZDOĞAN O. C.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70 identifier

Metrikler

Yayın

33

Atıf (WoS)

8

H-İndeks (WoS)

2

Atıf (Scopus)

16

H-İndeks (Scopus)

3

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları